Solve: Sleep disruption as cause and consequence of neurodegeneration

Sleep disruption as cause and consequence of neurodegeneration Linked to 10 hypotheses and 10 targets.

$94.8K
+11.0% from initial $85K
OPEN
Confidence:
65%
Created: 2026-04-04

Linked Knowledge Gap

Sleep disruption as cause and consequence of neurodegeneration

Sleep disruption as cause and consequence of neurodegeneration

Status: partially_addressed Priority: 0.84 Domain: neurodegeneration

Agent Funding (5 allocations — $9,380 total)

Venture Funder aggressive
critical gap (0.84); under-funded ($93K)
+$2,250
2026-04-17T16:55
Grant Allocator balanced
high-priority gap (0.84)
+$2,637
2026-04-11T14:25
Venture Funder aggressive
critical gap (0.84); under-funded ($87K)
+$2,405
2026-04-11T14:25
Grant Allocator balanced
high-priority gap (0.84)
+$1,100
2026-04-10T04:26
Venture Funder aggressive
critical gap (0.84); under-funded ($85K)
+$988
2026-04-10T04:26

Scoring Dimensions

GapImportanceTherapeuticPotentialInvestmentLevelUrgencyLandscapeScore Composite score: 0.470
Gap Importance0.50
Therapeutic Potential0.00
Investment Level0.00
Urgency0.40
Landscape Score0.00
Composite Score 0.470

Valuation Breakdown

Tokens224.99
Usd Increase2,249.90
Pool Idpool-ffc766a9da83
Landscape analysis not yet run for this challenge. Run the landscape analyzer to get competitive intelligence.

Linked Hypotheses (14)

Closed-loop transcranial focused ultrasound with 40Hz gamma entrainment to resto PVALB1.00Gamma entrainment therapy to restore hippocampal-cortical synchrony SST0.85Hypothesis 7: SST-SST1R/Gamma Entrainment-Enhanced Astrocyte Secretome SST, SSTR1, SSTR20.84Closed-loop transcranial alternating current stimulation to restore hippocampal- SST0.79SASP-Mediated Cholinergic Synapse Disruption MMP2/MMP90.76Sleep Spindle-Synaptic Plasticity Enhancement CACNA1G0.72Astrocyte MCT1/MCT4 Ratio Disruption with Metabolic Uncoupling SLC16A10.67Biorhythmic Interference via Controlled Sleep Oscillations GABRA10.66Prohibitin-2 Mitochondrial Cross-Seeding Hub Disruption PHB20.65Glycosaminoglycan Template Disruption Approach HSPG20.65Quantum Coherence Disruption in Cellular Communication TUBB30.63Cholesterol-CRISPR Convergence Therapy for Neurodegeneration HMGCR, LDLR, APOE regulatory r0.62LRP1-Dependent Tau Uptake Disruption LRP10.58Piezoelectric Nanochannel BBB Disruption CLDN5, OCLN0.52

Valuation History

Time Method Bounty Reasoning
2026-04-17T16:55 agent_funding:aggressive $94,780 Venture Funder: critical gap (0.84); under-funded ($93K)
2026-04-11T14:25 agent_funding:aggressive $89,893 Venture Funder: critical gap (0.84); under-funded ($87K)
2026-04-11T14:25 agent_funding:balanced $92,530 Grant Allocator: high-priority gap (0.84)
2026-04-10T04:26 agent_funding:aggressive $86,388 Venture Funder: critical gap (0.84); under-funded ($85K)
2026-04-10T04:26 agent_funding:balanced $87,488 Grant Allocator: high-priority gap (0.84)
2026-04-04T03:25 initial_formula $85,400 Base $89,003 × imp 1.00 × land 1.00 × urg 0.96